MyMedR

Displaying all 4 publications

Abstract:

Sort:

Antigenic proteins of Helicobacter pylori of potential diagnostic value

Khalilpour A, Santhanam A, Wei LC, Saadatnia G, Velusamy N, Osman S, et al.

Asian Pac J Cancer Prev, 2013;14(3):1635-42.
PMID: 23679248

Helicobacter pylori antigen was prepared from an isolate from a patient with a duodenal ulcer. Serum samples were obtained from culture-positive H. pylori infected patients with duodenal ulcers, gastric ulcers and gastritis (n=30). As controls, three kinds of sera without detectable H. pylori IgG antibodies were used: 30 from healthy individuals without history of gastric disorders, 30 from patients who were seen in the endoscopy clinic but were H. pylori culture negative and 30 from people with other diseases. OFF-GEL electrophoresis, SDS-PAGE and Western blots of individual serum samples were used to identify protein bands with good sensitivity and specificity when probed with the above sera and HRP-conjugated anti-human IgG. Four H. pylori protein bands showed good (≥ 70%) sensitivity and high specificity (98-100%) towards anti-Helicobacter IgG antibody in culture- positive patients sera and control sera, respectively. The identities of the antigenic proteins were elucidated by mass spectrometry. The relative molecular weights and the identities of the proteins, based on MALDI TOF/ TOF, were as follows: CagI (25 kDa), urease G accessory protein (25 kDa), UreB (63 kDa) and proline/pyrroline- 5-carboxylate dehydrogenase (118 KDa). These identified proteins, singly and/or in combinations, may be useful for diagnosis of H. pylori infection in patients.
Fulltext Can post-treatment oral cancer patients' concerns reflect their cancer characteristics, HRQoL, psychological distress level and satisfaction with consultation?

Aminnudin AN, Doss JG, Ismail SM, Chai MB, Abidin MZ, Basri CSJM, et al.

Ecancermedicalscience, 2020;14:1118.
PMID: 33209109 DOI: 10.3332/ecancer.2020.1118

Background: Oral cancer and its treatment impact patients' post-treatment outcomes, challenging clinicians to manage them optimally. Addressing patients' concerns is central to holistic patient-centred care.
Objectives: This study aimed to determine post-treatment oral cancer patients' concerns and its relationship with patients' clinical characteristics, health-related quality of life (HRQoL), psychological distress and patient satisfaction with the follow-up consultation.
Methods: A total of 85 oral cancer patients were recruited from a three-armed pragmatic RCT study on the patient concerns inventory for head and neck cancer (PCI-H&N), which was conducted at six hospital-based oral maxillofacial specialist clinics throughout Malaysia. Malaysians aged 18 years and above and on follow-ups from 1 month to 5 years or more were eligible. Patients completed the PCI-H&N, functional assessment of cancer therapy -H&N v4.0 and Distress Thermometer at pre-consultation and satisfaction questionnaire at post-consultation. The data were analysed descriptively; multiple linear regression and multivariate logistic regression analyses were used to determine possible predictors of patients' HRQoL and psychological distress.
Results: 'Recurrence or fear of cancer coming back' (31.8%) was most frequently selected. 43.5% of patients selected ≥4 concerns. A significantly high number of concerns were associated with patients of '1-month to 1-year post-treatment' (n = 84%; p = 0.001). A significant association existed between 'time after treatment completed' and patients' concerns of 'chewing/eating', 'mouth opening', 'swelling', 'weight', 'ability to perform', 'cancer treatment' and 'supplement/diet-related'. 'Chewing/eating' was predicted for low HRQoL (p < 0.0001) followed by 'appearance' and 'ability to perform recreation activities' (personal functions domain). Patients with high psychological distress levels were 14 times more likely to select 'ability to perform recreation activities' and seven times more likely to select 'feeling depressed'. No significant association was identified between patients' concerns and patients' satisfaction with the consultation.
Conclusion: Routine follow-up consultations should incorporate the PCI-H&N prompt list to enhance patient-centred care approach as the type and number of patients' concerns are shown to reflect their HRQoL and psychological distress.TRIAL REGISTRATION: NMRR-18-3624-45010 (IIR).
Modified TiO₂ nanotubes-zeolite composite photocatalyst: Characteristics, microstructure and applicability for degrading triclocarban

Arifin SNH, Radin Mohamed RMS, Al-Gheethi AA, Wei LC, Yashni G, Fitriani N, et al.

Chemosphere, 2022 Jan;287(Pt 3):132278.
PMID: 34826939 DOI: 10.1016/j.chemosphere.2021.132278

The study explored the characteristics and effectiveness of modified TiO2 nanotubes with zeolite as a composite photocatalyst (MTNZC) for the degradation of triclocarban (TCC) from the aqueous solution. MTNZC samples have been produced via electrochemical anodisation (ECA) followed by electrophoretic deposition (EPD). Three independent factors selected include MTNZC size (0.5-1 cm2), pH (3-10), and irradiation time (10-60 min). The observation revealed that the surface of Ti substrate by the 40 V of anodisation and 3 h of calcination was covered with the array ordered, smooth and optimum elongated nanotubes with average tube length was approximately 5.1 μm. EDS analysis proved the presence of Si, Mg, Al, and Na on MTNZC due to the chemical composition present in the zeolite. The average crystallite size of TiO₂ nanotubes increased from 2.07 to 3.95 nm by increasing anodisation voltage (10, 40, and 60 V) followed by 450 °C of calcination for 1, 3, and 6 h, respectively. The optimisation by RSM shows the F-value (36.12), the p-value of all responses were less than 0.0001, and the 95% confidence level of the model by all the responses indicated the model was significant. The R2 in the range of 0.9433-0.9906 showed the suitability of the model to represent the actual relationship among the parameters. The photocatalytic degradation rate of TCC from the first and the fifth cycles were 94.2 and 77.4%, indicating the applicability of MTNZC to be used for several cycles.
Fulltext Shape-controlled synthesis of zinc nanostructures mediating macromolecules for biomedical applications

Mousavi SM, Behbudi G, Gholami A, Hashemi SA, Nejad ZM, Bahrani S, et al.

Biomater Res, 2022 Feb 02;26(1):4.
PMID: 35109931 DOI: 10.1186/s40824-022-00252-y

Zinc nanostructures (ZnONSs) have attracted much attention due to their morphological, physicochemical, and electrical properties, which were entailed for various biomedical applications such as cancer and diabetes treatment, anti-inflammatory activity, drug delivery. ZnONS play an important role in inducing cellular apoptosis, triggering excess reactive oxygen species (ROS) production, and releasing zinc ions due to their inherent nature and specific shape. Therefore, several new synthetic organometallic method has been developed to prepare ZnO crystalline nanostructures with controlled size and shape. Zinc oxide nanostructures' crystal size and shape can be controlled by simply changing the physical synthesis condition such as microwave irradiation time, reaction temperature, and TEA concentration at reflux. Physicochemical properties which are determined by the shape and size of ZnO nanostructures, directly affect their biological applications. These nanostructures can decompose the cell membrane and accumulate in the cytoplasm, which leads to apoptosis or cell death. In this study, we reviewed the various synthesis methods which affect the nano shapes of zinc particles, and physicochemical properties of zinc nanostructures that determined the shape of zinc nanomaterials. Also, we mentioned some macromolecules that controlled their physicochemical properties in a green and biological approaches. In addition, we present the recent progress of ZnONSs in the biomedical fields, which will help centralize biomedical fields and assist their future research development.